Several outlets have published reviews of notable patent cases and developments in 2025. The focus of these reviews varies, with some covering patent decisions globally, others focusing on specific regions like France, and still others discussing intellectual property developments more broadly. The scope of the reviews also differs, with some highlighting top patent cases, while others discuss upcoming changes, such as drugs losing US exclusivity in 2026.